» Articles » PMID: 27267934

Fermentation Properties and Potential Prebiotic Activity of Bimuno® Galacto-oligosaccharide (65 % Galacto-oligosaccharide Content) on in Vitro Gut Microbiota Parameters

Overview
Journal Br J Nutr
Date 2016 Jun 9
PMID 27267934
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Prebiotic oligosaccharides have the ability to generate important changes in the gut microbiota composition that may confer health benefits to the host. Reducing the impurities in prebiotic mixtures could expand their applications in food industries and improve their selectivity and prebiotic effect on the potential beneficial bacteria such as bifidobacteria and lactobacilli. This study aimed to determine the in vitro potential fermentation properties of a 65 % galacto-oligosaccharide (GOS) content Bimuno® GOS (B-GOS) on gut microbiota composition and their metabolites. Fermentation of 65 % B-GOS was compared with 52 % B-GOS in pH- and volume-controlled dose-response anaerobic batch culture experiments. In total, three different doses (1, 0·5 and 0·33 g equivalent to 0·1, 0·05 and 0·033 g/l) were tested. Changes in the gut microbiota during a time course were identified by fluorescence in situ hybridisation, whereas small molecular weight metabolomics profiles and SCFA were determined by 1H-NMR analysis and GC, respectively. The 65 % B-GOS showed positive modulation of the microbiota composition during the first 8 h of fermentation with all doses. Administration of the specific doses of B-GOS induced a significant increase in acetate as the major SCFA synthesised compared with propionate and butyrate concentrations, but there were no significant differences between substrates. The 65 % B-GOS in syrup format seems to have, in all the analysis, an efficient prebiotic effect. However, the applicability of such changes remains to be shown in an in vivo trial.

Citing Articles

Should we consider microbiota-based interventions as a novel therapeutic strategy for schizophrenia? A systematic review and meta-analysis.

Hassib L, Kanashiro A, Pedrazzi J, Vercesi B, Higa S, Arruda I Brain Behav Immun Health. 2025; 43():100923.

PMID: 39839986 PMC: 11745983. DOI: 10.1016/j.bbih.2024.100923.


Daily consumption of galactooligosaccharide gummies ameliorates constipation symptoms, gut dysbiosis, degree of depression and quality of life among sedentary university teaching staff: A double-blind randomized placebo control clinical trial.

Dey K, Sheth M, Anand S, Archana G, Raval S Indian J Gastroenterol. 2023; 42(6):839-848.

PMID: 37751049 DOI: 10.1007/s12664-023-01435-8.


Prebiotic and Anti-Adipogenic Effects of Radish Green Polysaccharide.

Lee Y, Lee H, Kim Y, Shin K, Park H Microorganisms. 2023; 11(7).

PMID: 37513035 PMC: 10385334. DOI: 10.3390/microorganisms11071862.


Chronic consumption of a blend of inulin and arabinoxylan reduces energy intake in an ad libitum meal but does not influence perceptions of appetite and satiety: a randomised control-controlled crossover trial.

Collins S, Gibson G, Stainton G, Bertocco A, Kennedy O, Walton G Eur J Nutr. 2023; 62(5):2205-2215.

PMID: 37046122 DOI: 10.1007/s00394-023-03136-6.


Effects of the Administration of subsp. CECT 7210 and HN001 and Their Synbiotic Combination With Galacto-Oligosaccharides Against Enterotoxigenic F4 in an Early Weaned Piglet Model.

Rodriguez-Sorrento A, Castillejos L, Lopez-Colom P, Cifuentes-Orjuela G, Rodriguez-Palmero M, Moreno-Munoz J Front Microbiol. 2021; 12:642549.

PMID: 33935999 PMC: 8086512. DOI: 10.3389/fmicb.2021.642549.


References
1.
Tzortzis G, Goulas A, Gee J, Gibson G . A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J Nutr. 2005; 135(7):1726-31. DOI: 10.1093/jn/135.7.1726. View

2.
Schmidt K, Cowen P, Harmer C, Tzortzis G, Errington S, Burnet P . Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl). 2014; 232(10):1793-801. PMC: 4410136. DOI: 10.1007/s00213-014-3810-0. View

3.
Costabile A, Walton G, Tzortzis G, Vulevic J, Charalampopoulos D, Gibson G . Effects of orange juice formulation on prebiotic functionality using an in vitro colonic model system. PLoS One. 2015; 10(3):e0121955. PMC: 4373861. DOI: 10.1371/journal.pone.0121955. View

4.
Vulevic J, Juric A, Tzortzis G, Gibson G . A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013; 143(3):324-31. DOI: 10.3945/jn.112.166132. View

5.
Rycroft C, Jones M, Gibson G, Rastall R . Fermentation properties of gentio-oligosaccharides. Lett Appl Microbiol. 2001; 32(3):156-61. DOI: 10.1046/j.1472-765x.2001.00875.x. View